Cargando…
Precision Nutrition and the Microbiome Part II: Potential Opportunities and Pathways to Commercialisation
Modulation of the human gut microbiota through probiotics, prebiotics and dietary fibre are recognised strategies to improve health and prevent disease. Yet we are only beginning to understand the impact of these interventions on the gut microbiota and the physiological consequences for the human ho...
Autores principales: | Mills, Susan, Lane, Jonathan A., Smith, Graeme J., Grimaldi, Keith A., Ross, R. Paul, Stanton, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683087/ https://www.ncbi.nlm.nih.gov/pubmed/31252674 http://dx.doi.org/10.3390/nu11071468 |
Ejemplares similares
-
Precision Nutrition and the Microbiome, Part I: Current State of the Science
por: Mills, Susan, et al.
Publicado: (2019) -
Nanotechnology commercialisation
por: Tsuzuki, Takuya
Publicado: (2013) -
The Commercialisation of Medical and Scientific Reporting
por: Caulfield, Timothy
Publicado: (2004) -
Conference on the Commercialisation of Microsystems '96
Publicado: (1996) -
Commercialisation and entrepreneurship – an academic viewpoint
Publicado: (2022)